Citigroup Downgrades Brightpoint To Hold, PT To $11
Citigroup has downgraded Brightpoint (NASDAQ: CELL) from Buy to Hold and has lowered the price target from $17.50 to $11.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted-In: Brightpoint Inc. CitigroupDowngrades Price Target Analyst Ratings